Merck Millipore introduces Millipore Express PHF hydrophilic sterilizing-grade filters for fast, efficient and economical buffer filtration
![](/46/pdcnewsitem/03/76/09/merck%20millipore.jpg)
Faster flow rates than most sterilizing-grade filters, reducing footprint.
Merck Millipore hasintroduced Millipore Express PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration. The single layer, fast-flowing 0.2 µm PES membrane filters provide sterilizing-grade performance and are ideal for buffers, pH adjusters and other process additives and intermediate fluids as well as cleaning fluids. The single-use, gamma ready filters are available in a fully scalable range of sizes from 25 mm to 76.2 cm cartridges.
The filters are designed to offer high-flux performance and improved process economics. Superior process efficiency and economy result from broad chemical compatibility, high flow rates and extended throughput. Offering faster flow rates than most sterilizing-grade filters, Millipore Express filters allow users to accelerate their processes with the same size filter or reduce their process footprint, using a smaller filter.
Millipore Express PHF filters are compatible with a wide range of buffer chemistries including acids and sodium hydroxide across the entire pH range. The filters can withstand multiple steam-in-place or autoclave sterilization cycles.
"Improving process economics is always an imperative for our customers," said Andrew Bulpin, Vice President, Process Solutions, Merck Millipore. "With a fast flowing membrane design, Millipore Express PHF filters can be used to accelerate current processes or run the same process with a smaller filter footprint. And with a comprehensive range of sizes, these filters can support scale up and technology transfer with ease."
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance